Drug Resistance, Microbial
"Drug Resistance, Microbial" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS).
| Descriptor ID |
D004352
|
| MeSH Number(s) |
G06.225 G07.690.773.984.269
|
| Concept/Terms |
Drug Resistance, Microbial- Drug Resistance, Microbial
- Drug Resistances, Microbial
- Antimicrobial Drug Resistance
- Antimicrobial Drug Resistances
|
Below are MeSH descriptors whose meaning is more general than "Drug Resistance, Microbial".
Below are MeSH descriptors whose meaning is more specific than "Drug Resistance, Microbial".
This graph shows the total number of publications written about "Drug Resistance, Microbial" by people in this website by year, and whether "Drug Resistance, Microbial" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 9 | 9 |
| 1995 | 2 | 5 | 7 |
| 1996 | 1 | 6 | 7 |
| 1997 | 2 | 11 | 13 |
| 1998 | 1 | 7 | 8 |
| 1999 | 1 | 6 | 7 |
| 2000 | 1 | 12 | 13 |
| 2001 | 2 | 10 | 12 |
| 2002 | 0 | 3 | 3 |
| 2003 | 2 | 1 | 3 |
| 2004 | 0 | 1 | 1 |
| 2005 | 1 | 3 | 4 |
| 2006 | 1 | 0 | 1 |
| 2007 | 0 | 1 | 1 |
| 2009 | 1 | 2 | 3 |
| 2010 | 1 | 0 | 1 |
| 2011 | 1 | 2 | 3 |
| 2012 | 0 | 4 | 4 |
| 2013 | 1 | 2 | 3 |
| 2014 | 5 | 1 | 6 |
| 2015 | 0 | 1 | 1 |
| 2016 | 0 | 2 | 2 |
| 2018 | 2 | 0 | 2 |
| 2020 | 3 | 3 | 6 |
| 2021 | 1 | 2 | 3 |
| 2022 | 0 | 2 | 2 |
| 2023 | 0 | 4 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Drug Resistance, Microbial" by people in Profiles.
-
Primary antibiotic resistance of Helicobacter pylori in the Asia-Pacific region between 1990 and 2022: an updated systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2024 Jan; 9(1):56-67.
-
Drugging evolution of antibiotic resistance at a regulatory network hub. Sci Adv. 2023 06 23; 9(25):eadg0188.
-
Use of point-of-care biomarkers to reduce antibiotic resistance. Lancet Infect Dis. 2023 09; 23(9):996-997.
-
Mapping the determinants of catalysis and substrate specificity of the antibiotic resistance enzyme CTX-M ?-lactamase. Commun Biol. 2023 01 12; 6(1):35.
-
Stress-Induced Mutagenesis, Gambler Cells, and Stealth Targeting Antibiotic-Induced Evolution. mBio. 2022 06 28; 13(3):e0107422.
-
Comparable Results of Helicobacter pylori Antibiotic Resistance Testing of Stools vs Gastric Biopsies Using Next-Generation Sequencing. Gastroenterology. 2022 06; 162(7):2095-2097.e2.
-
The Five Ds of Outpatient Antibiotic Stewardship for Urinary Tract Infections. Clin Microbiol Rev. 2021 12 15; 34(4):e0000320.
-
Resistance to Antifungal Drugs. Infect Dis Clin North Am. 2021 06; 35(2):279-311.
-
Helicobacter pylori infection and antibiotic resistance - from biology to clinical implications. Nat Rev Gastroenterol Hepatol. 2021 09; 18(9):613-629.
-
Skin and Soft Tissue Infections in Non-Human Immunodeficiency Virus Immunocompromised Hosts. Infect Dis Clin North Am. 2021 Mar; 35(1):199-217.